Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

COMPASS Pathways plc (CMPS) Market Cap & Valuation Ratios

COMPASS Pathways plc (CMPS) has a market cap of $1.5B, with earnings according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

CMPSCOMPASS Pathways plcFollow CMPS — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
1.5B
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
2 Nov, in 9 days

Peers

drug manufacturers - general · nearest by market cap · trailing 12 months
CompanyMkt cap, $BP/EEV/SalesEV/EBITDAFCF yieldRev. growthOp. marginROIC
CMPS1.5———————
ZLAB2.7—5.2—-5.2%+5%-59%-112%
HCM2.5143.62.2—0.4%-9%-6%-3%
BHC2.4—2.010.4—+10%8%4%
NAMS2.4—241.9—-6.1%-89%—-116%
BRVE1.9———————
GENB1.6———————
QURE1.6—42.6—-10.4%+30%——
GPCR1.5———-14.9%——-30%
MLTX1.0——————-315%
SLN0.9———-4.5%-98%——
Median of these 10143.65.210.4-5.6%-2%-6%-71%

.

Growth vs. price

each dot a company · hover or tap for values

COMPASS Pathways plc — questions

What is COMPASS Pathways plc's market cap?
$1.5B.

Every figure on this page comes from COMPASS Pathways plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.